This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 8| Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
|---|---|---|---|---|---|---|---|---|---|
| 2088 | Aspartate aminotransferase to white blood cell count ratio (AWR) | Others | Human | AWR > 5.2 was an adverse predictor of DFS and OS in HCC after hepatectomy | Prognostic | HCC patients with AWR >5.2 v/s HCC patients with AWR <5.2; predict survival of patients | p < 0.01 | Blood | 27057915 |
| 2107 | Combination of S100A9 and GRN | Others | Human | Downregulated in HCC patients | Diagnostic and Prognostic | Normal vs HCC | p < 0.001 | Urine | 26675302 |
| 2111 | qEASL | Method (Others) | Human | NA | Predictive | TACE responder v/s TACE non-responder | p < 0.05 | Tissue | 26131913 |
| 2112 | vRECIST | Method (Others) | Human | NA | Predictive | TACE responder v/s TACE non-responder | p < 0.05 | Tissue | 26131913 |
| 2127 | DNA hypomethylated regions of GPM6B | Epigenetic (Others) | Human | hypomethylated and Upregulated level in HCC | Diagnostic | Cancer v/s Normal | p < 0.01 | Tissue | 23950870 |
| 2128 | DNA hypomethylated regions of MAGEA12 | Epigenetic (Others) | Human | hypomethylated and Upregulated level in HCC | Diagnostic | Cancer v/s Normal | p < 0.01 | Tissue | 23950870 |
| 2129 | DNA hypomethylated regions of FCRL1 | Epigenetic (Others) | Human | hypomethylated and Upregulated level in HCC | Diagnostic | Invasive HCC v/s non-invasive HCC | p < 0.01 | Tissue | 23950870 |
| 2207 | NLR (neutrophil to lymphocyte ratio) and SII (Systemic Immune-Inflammation Index) | Neutrophils and lyphocytes (Others) | Human | NLR and SII in patients associated with more advanced stages of HCC | Prognostic | Normal vs HCC; associated with TNM stage, PST and survival of patients | p < 0.05 | Blood | 29123264 |